Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marc W. Klutstein is active.

Publication


Featured researches published by Marc W. Klutstein.


Catheterization and Cardiovascular Diagnosis | 1997

Treatment of spontaneous coronary artery dissection: Report of three cases

Marc W. Klutstein; Dan Tzivoni; Dani Bitran; Boaz Mendzelevski; Michael Ilan; Yaron Almagor

Spontaneous coronary artery dissection is an extremely rare cause of myocardial infarction. It has been reported mainly in young women during or after pregnancy. The prognosis and treatment of coronary dissection are not clear. We report three cases of spontaneous coronary artery dissection in young women. One of them was pregnant and one was 2 weeks after delivery. The dissection involved the left anterior descending artery (LAD) in two cases and the left main coronary artery in one case. There was no evidence of atherosclerosis on angiography or intracoronary ultrasound in any of the patients. Two of the women were treated by stent implantation with excellent results. This is the first known report of successful coronary stenting of spontaneous coronary artery dissection. The pregnant woman was not a candidate for stent implantation and underwent implantation of the left internal mammary to the LAD without cardiopulmonary bypass. She completed her pregnancy uneventfully.


The Annals of Thoracic Surgery | 2009

Repair of Ischemic Mitral Regurgitation: Comparison Between Flexible and Rigid Annuloplasty Rings

Shuli Silberman; Marc W. Klutstein; Tsipora Sabag; Avraham Oren; Daniel Fink; Ofer Merin; Daniel Bitran

BACKGROUND The surgical treatment of ischemic mitral regurgitation (MR) usually involves implantation of an annuloplasty ring. We compared results of mitral valve repair using a flexible or a rigid annuloplasty ring in patients with ischemic MR undergoing coronary artery bypass graft surgery. METHODS There were 169 patients. A flexible ring was implanted in 117 and a rigid ring in 52. Age and clinical profile, degree of left ventricular dysfunction, and degree of MR (mean 3.2) were similar between groups. RESULTS Operative mortality was 9% in each group. Follow-up (58 +/- 30 months for flexible group and 14 +/- 7 months for rigid group) was available for 91%. For the flexible and rigid ring groups, respectively, mean New York Heart Association functional class was 1.9 and 1.6, with 33% and 14% in classes III to IV (p = 0.03); mean MR grade was 1.25 and 0.7 (p = 0.006). There was no difference in left ventricle function or dimensions. At follow-up, 29 patients (34%) in the flexible group had residual MR of moderate degree or greater compared with 6 (15%) in the rigid group (p = 0.03). Mean tricuspid incompetence gradient was 39 and 34 mm Hg (p = nonsignificant); however, the degree of reduction was greater in the rigid group (p = 0.001). Late mortality was observed in 32 patients, all in the flexible group. CONCLUSIONS Clinical and hemodynamic results are better with rigid mitral annuloplasty rings compared with flexible rings. That result may be due to ring design, which dictates not only the annular diameter but also annular configuration. Longer follow-up is needed to determine differences in survival.


American Journal of Cardiology | 2000

Effect of surgical repair of secundum-type atrial septal defect on right atrial, right ventricular, and left ventricular volumes in adults

Joseph Shaheen; Liat Alper; David Rosenmann; Marc W. Klutstein; George Falkowsky; Dani Bitran; Dan Tzivoni

Surgical repair of atrial septal defect in adults reduces right ventricular and right atrial diameters and volumes, and improves left ventricular filling.


American Heart Journal | 2013

Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy

Marc W. Klutstein; Cynthia M. Westerhout; Paul W. Armstrong; Robert P. Giugliano; Basil S. Lewis; C. Michael Gibson; Sohrab Lutchmedial; Petr Widimsky; P. Gabriel Steg; Anthony J. Dalby; Uwe Zeymer; Frans Van de Werf; Robert A. Harrington; L. Kristin Newby; Sunil V. Rao

BACKGROUND Bleeding is a major limitation of antithrombotic therapy among invasively managed non-ST-segment elevation acute coronary syndromes (NSTE-ACS) patients; therefore, we examined the use of radial access and its association with outcomes among NSTE-ACS patients. METHODS Clinical characteristics and geographic variation in radial access were examined, as well as its association with bleeding, red blood cell transfusion and ischemic outcomes (96-hour death/myocardial infarction/recurrent ischemic/thrombotic bailout; 30-day death/myocardial infarction; 1-year death) in the EARLY versus delayed, provisional eptifibatide in acute coronary syndromes trial. RESULTS Of 9126 patients, 13.5% underwent radial-access catheterization. Female sex, age, weight, and prior revascularization were inversely associated with radial access, and its use varied widely by country (2%-97%). There were fewer GUSTO severe/moderate bleeds and red blood cell transfusions in the radial access group; however, it was attenuated after adjustment (odds ratio 0.73, 95% confidence intervals [CI] [0.50-1.06], P = .094 and 1.00 [0.71-1.40] P = .991). Ischemic outcomes did not differ by access site. CONCLUSIONS In this post hoc analysis of a large clinical trial, there was significant international variation in use of radial access for NSTE-ACS patients undergoing invasive management, and it was preferentially used in those at lower risk for bleeding. Radial approach was not associated with a significant reduction in either bleeding or ischemic outcomes. Further study is needed to determine whether wider application of radial approach to acute coronary syndrome patients at high risk for bleeding improves overall outcomes.


The Cardiology | 2006

Transient Left Ventricular Apical Ballooning

David Rosenmann; Jonathan Balkin; Adi Butnaru; Kenneth Wanderman; Marc W. Klutstein; Dan Tzivoni

Background: Transient left ventricular (LV) apical ballooning is characterized by acute onset of chest pain with reversible balloon-like LV motion abnormality, hypercontractile basal segments, ST segment elevation or T-wave inversion in anterior chest leads and mild cardiac enzyme rise in the absence of significant coronary disease. Methods: We describe 5 patients (4 females) with anteroapical ballooning who were hospitalized with acute myocardial infarction and showed ST segment elevation in anterior chest leads. Results: Echocardiogram demonstrated apical ballooning with normal or hypercontractile contraction of the basal segments. Four patients had severe mitral incompetence and one had mild incompetence. All patients had also systolic anterior motion and 4 had a significant LV outflow (LVOT) gradient. All patients underwent cardiac catheterization soon after admission showing non-significant narrowing of the coronary arteries. At discharge 4 patients had normal LV function and 1 was mildly impaired. Conclusions: LV apical ballooning is relatively rare. It should be suspected in older patients, mainly women, with severe mitral incompetence and LVOT gradient.


Cardiovascular Drugs and Therapy | 2000

The effect of mibefradil on ischemic episodes with and without increase in heart rate.

Dan Tzivoni; Zvi Gilula; Marc W. Klutstein; Leonardo Reisin; Shulamit Botvin; Isaac Kobrin

Myocardial ischemia during daily life can be induced by increased demand and by increased coronary tone. The purpose of this study was to assess the mechanism of action of mibefradil, a new T-channel calcium blocker that is a vasodilator with negative chronotropic properties. Included in this study were 114 patients with chronic stable angina pectoris and ischemic episodes during baseline 48-hour ambulatory ECG monitoring (AEM). After a placebo run-in period patients received 50 mg, 100 mg, or 150 mg of mibefradil per day and repeat 48 hours AEM was performed. Ischemic episodes were divided into 2 categories: Type I is those in which an increase in heart rate >10% preceded the development of 1 mm ST depression; Type II is those with ≤10% increase in heart rate. Of the 625 ischemic episodes recorded at baseline, 83% were Type I and 17% were Type II. At 50 mg mibefradil dose, there was a significant decrease in the number of Type I ischemic episodes but not of Type II. At doses of 100 mg and 150 mg/day, there was a significant decrease in frequency of both Types of ischemic episodes. At a low dose of 50 mg/day, mibefradil reduces ischemia predominantly by preventing an increase in heart rate, while at higher doses of 100 mg and 150 mg/day, it also acted as a vasodilator suppressing episodes associated with increased coronary tone.


European Heart Journal | 1999

Prevalence and significance of left ventricular outflow gradient during dobutamine echocardiography

D. Luria; Marc W. Klutstein; David Rosenmann; Joseph Shaheen; S. Sergey; Dan Tzivoni


Chest | 2004

Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes*

Daniel Monakier; Michal Mates; Marc W. Klutstein; Jonathan Balkin; Bernard Rudensky; David Meerkin; Dan Tzivoni


Blood Cells Molecules and Diseases | 2005

C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.

Deborah Elstein; Amiram Nir; Marc W. Klutstein; Bernard Rudensky; Ari Zimran


Nephrology Dialysis Transplantation | 2005

Anaemia and heart failure: aetiology and treatment

Marc W. Klutstein; Dan Tzivoni

Collaboration


Dive into the Marc W. Klutstein's collaboration.

Top Co-Authors

Avatar

Dan Tzivoni

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

David Rosenmann

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Adi Butnaru

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Basil S. Lewis

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Michael Gibson

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge